Dr. Fouad Atouf, PhD

Executive Vice President, and Chief Science Officer at US Pharmacopeia

Speaker

As Chief Science Officer, Fouad leads USP’s scientific strategy and the development of quality standards for small molecules, biologics, dietary supplements, food ingredients, and healthcare practice. He oversees the USP global science division and leads USP’s Science Quality Framework, guiding the organization’s scientific priorities including supporting pharmaceutical innovation and identifying areas where standardization and quality solutions can have the greatest impact. He collaborates with other organizations on the exploration of emerging technologies, so that the resulting methods and quality standards meet the needs of the stakeholders. As Chair of the Council of Experts, Fouad oversees the work of USP’s Expert Committees and serves as the Chair of the Council of Experts, USP’s highest scientific governance body, responsible for the scientific direction and development of standards. Fouad joined USP in 2006 and has served in multiple scientific leadership roles developing quality tools for biologics and establishing relevant reference material programs. In addition to leading the modernization of existing standards, Fouad played a central role in the launch of USP’s biologics strategy in 2017, and since then has led its implementation, focusing on technologies used to manufacture and test new modalities of biological medicines. Leading the overall management and accountability for USP’s Biologics business unit, he used innovative approaches in launching USP’s biological offerings and developed forward-looking models for engagement and collaboration—strategically designed to meet the evolving needs of stakeholders across academia, the biopharma industry, and global government agencies. Recognized as a thought leader in the life sciences sector, Fouad is relied upon for his expertise, frequently representing USP at global pharmaceutical regulatory science and biotechnology events. Fouad has built a network of strong relationships with global regulators and pharmacopeias, industry, and other stakeholders. Fouad’s stewardship of the USP’s scientific collaborations with other standard-setting organizations and global pharmacopeias drives knowledge sharing and regulatory convergence on emerging science quality challenges that accelerate access to critical medicines. His collaborations with industry and other organizations help identify key quality challenges, build consensus, and advance development of innovative solutions that can support the next generation of pharmacopeial methods and quality standards to meet the changing needs of stakeholders.